Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT06058793
Title	Brightline-4: A Study to Test How Well Brigimadlin is Tolerated by People With a Type of Cancer Called Dedifferentiated Liposarcoma
Recruitment	Active, not recruiting
Gender	both
Phase	Phase III
Variant Requirements	Yes
Sponsors	Boehringer Ingelheim
Indications	dedifferentiated liposarcoma
Therapies	BI 907828
Age Groups:	adult \| senior
Covered Countries	USA \| ITA \| GBR \| CAN \| BRA \| BEL \| AUS \| ARG